Michael D. Serby

822 total citations
13 papers, 495 citations indexed

About

Michael D. Serby is a scholar working on Molecular Biology, Surgery and Infectious Diseases. According to data from OpenAlex, Michael D. Serby has authored 13 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Infectious Diseases. Recurrent topics in Michael D. Serby's work include Cholesterol and Lipid Metabolism (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Hepatitis C virus research (3 papers). Michael D. Serby is often cited by papers focused on Cholesterol and Lipid Metabolism (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Hepatitis C virus research (3 papers). Michael D. Serby collaborates with scholars based in United States, United Kingdom and Egypt. Michael D. Serby's co-authors include Zhili Xin, Hing L. Sham, Bruce G. Szczepankiewicz, Hongyu Zhao, Heidi S. Camp, Christine A. Collins, Ning Cao, Teresa K. Surowy, Anthony Lee and James M. Trevillyan and has published in prestigious journals such as Journal of Medicinal Chemistry, Drug Metabolism and Disposition and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Michael D. Serby

13 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Serby United States	11	313	90	80	68	63	13	495
Denis McCann United States	15	566 1.8×	85 0.9×	63 0.8×	41 0.6×	62 1.0×	26	826
Dean J. Welsch United States	13	313 1.0×	44 0.5×	188 2.4×	25 0.4×	60 1.0×	22	686
Thomas Maduskuie United States	12	210 0.7×	129 1.4×	31 0.4×	25 0.4×	47 0.7×	22	477
Michael W. Lago United States	10	209 0.7×	91 1.0×	30 0.4×	53 0.8×	58 0.9×	13	538
Akito Hata Japan	11	217 0.7×	39 0.4×	82 1.0×	23 0.3×	26 0.4×	16	516
Angelina M. Santini United States	15	338 1.1×	136 1.5×	24 0.3×	43 0.6×	31 0.5×	27	646
Peter B. Ehmer Germany	8	176 0.6×	86 1.0×	24 0.3×	32 0.5×	34 0.5×	12	584
Janice Darlington Türkiye	12	293 0.9×	82 0.9×	21 0.3×	39 0.6×	27 0.4×	16	490
Edward C. Giardino United States	13	175 0.6×	174 1.9×	56 0.7×	26 0.4×	47 0.7×	20	507
Hiroshi Shirota Japan	11	141 0.5×	153 1.7×	49 0.6×	24 0.4×	36 0.6×	39	513

Countries citing papers authored by Michael D. Serby

Since Specialization

Citations

This map shows the geographic impact of Michael D. Serby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Serby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Serby more than expected).

Fields of papers citing papers by Michael D. Serby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Serby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Serby. The network helps show where Michael D. Serby may publish in the future.

Co-authorship network of co-authors of Michael D. Serby

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Serby. A scholar is included among the top collaborators of Michael D. Serby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Serby. Michael D. Serby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Serby, Michael D., Anthony Lee, Xiaomei Zhang, et al.. (2016). Metabolism and Disposition of the Hepatitis C Protease Inhibitor Paritaprevir in Humans. Drug Metabolism and Disposition. 44(8). 1164–1173. 16 indexed citations

Liu, Hong, Yanbin Lao, Katty Wan, et al.. (2016). Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites. Drug Metabolism and Disposition. 45(3). 294–305. 77 indexed citations

Shen, Jie, Michael D. Serby, Bruce W. Surber, et al.. (2016). Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans. Drug Metabolism and Disposition. 44(8). 1148–1157. 16 indexed citations

Shen, Jie, Michael D. Serby, Anthony Lee, et al.. (2016). Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in Humans. Drug Metabolism and Disposition. 44(8). 1139–1147. 17 indexed citations

Xin, Zhili, Hongyu Zhao, Michael D. Serby, et al.. (2008). Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(15). 4298–4302. 64 indexed citations

Zhao, Hongyu, Michael D. Serby, & Bo Liu. (2008). The prospects of antagonizing the growth hormone secretagogue receptor to treat obesity. Expert Opinion on Therapeutic Patents. 18(9). 989–998. 1 indexed citations

Zhao, Hongyu, Michael D. Serby, Ning Cao, et al.. (2007). Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(12). 3388–3391. 26 indexed citations

Liu, Gang, J.A. Lynch, Jennifer C. Freeman, et al.. (2007). Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors. Journal of Medicinal Chemistry. 50(13). 3086–3100. 102 indexed citations

Liu, Bo, Mei Liu, Zhili Xin, et al.. (2006). Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: Side chain exploration. Bioorganic & Medicinal Chemistry Letters. 16(7). 1864–1868. 11 indexed citations

10.

Liu, Gang, Hongyu Zhao, Bo Liu, et al.. (2006). Hemodynamic effects of potent and selective JNK inhibitors in anesthetized rats: Implication for targeting protein kinases in metabolic diseases. Bioorganic & Medicinal Chemistry Letters. 17(2). 495–500. 10 indexed citations

11.

Zhao, Hongyu, Michael D. Serby, Zhili Xin, et al.. (2006). Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide c-Jun NH₂-Terminal Kinase Inhibitors. Journal of Medicinal Chemistry. 49(15). 4455–4458. 64 indexed citations

12.

Xin, Zhili, Hongyu Zhao, Michael D. Serby, et al.. (2004). Synthesis and structure–activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(4). 1201–1204. 17 indexed citations

13.

Zhao, Hongyu, Gang Liu, Zhili Xin, et al.. (2004). Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(22). 5543–5546. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact